Question 1

What is MRNA stock price today?

Accepted Answer

Moderna, Inc. (MRNA) is currently trading at $78.78, up 8.67% today.

Question 2

What is MRNA market cap?

Accepted Answer

Moderna, Inc. has a market capitalization of $29 billion, making it one of the notable companies in the Healthcare sector.

Question 3

What is MRNA P/E ratio?

Accepted Answer

Moderna, Inc. has a P/E ratio of -9.67, which measures the stock price relative to its earnings per share.

Question 4

What is MRNA price target?

Accepted Answer

The average analyst price target for Moderna, Inc. is $42.80, which represents a -45.7% downside from the current price.

Question 5

What is MRNA 52-week high and low?

Accepted Answer

Moderna, Inc.'s 52-week high is $81.38 and 52-week low is $22.28. The current price of $78.78 is 96% of its 52-week range.

Question 6

What do analysts say about MRNA?

Accepted Answer

Analysts currently rate Moderna, Inc. as Hold. Coverage is updated daily from major firms.

Question 7

Does MRNA pay a dividend?

Accepted Answer

Moderna, Inc. (MRNA) does not currently pay a dividend. The company reinvests profits back into growth and operations.

Question 8

Is MRNA revenue growing?

Accepted Answer

Moderna, Inc. has a year-over-year revenue growth rate of +263.6%. This indicates strong growth momentum.

Question 9

What sector is MRNA in?

Accepted Answer

Moderna, Inc. (MRNA) operates in the Healthcare sector within the Biotechnology industry. You can explore other stocks in this sector on our Healthcare sector page.

Question 10

How has MRNA performed this year?

Accepted Answer

Moderna, Inc. (MRNA) has a year-to-date return of +145.8%. This significantly outperforms the broader market.

Question 11

Is MRNA overvalued or undervalued?

Accepted Answer

Moderna, Inc. has a forward P/E ratio of -11.7 compared to its trailing P/E of -9.7. A lower forward P/E suggests analysts expect earnings growth. Visit the MRNA stock page for detailed valuation analysis.

Moderna, Inc.

Price chart

Price performance

The thesis at a glance

Who's buying MRNA right now

Recent earnings results

7 analysts · 14% Buy

How MRNA stacks vs Biotechnology

Peers & themes